BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for Reflotron Hemoglobin, Roche

2013.07.11

Product group In-vitro diagnostics - equipment / products for clinical chemistry
Reference 00475/13

Corrective action from Roche for Reflotron Hemoglobin due to a bias of results obtained in capillary blood. Customers were informed accordingly.

Corrective action for Reflotron Hemoglobin, Roche , Download_VeroeffentlichtAm_EN PDF, 57KB, File does not meet accessibility standards

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK